0.600
0.03 (4.95%)
| Penutupan Terdahulu | 0.572 |
| Buka | 0.551 |
| Jumlah Dagangan | 86,824 |
| Purata Dagangan (3B) | 222,687 |
| Modal Pasaran | 14,825,856 |
| Harga / Jualan (P/S) | 34.02 |
| Harga / Buku (P/B) | 2.19 |
| Julat 52 Minggu |
| Margin Keuntungan | -147.39% |
| Margin Operasi (TTM) | -191.83% |
| EPS Cair (TTM) | -0.050 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -34.30% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 4.01% |
| Nisbah Semasa (MRQ) | 12.40 |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -1.48 M |
| Pulangan Atas Aset (ROA TTM) | -11.55% |
| Pulangan Atas Ekuiti (ROE TTM) | -20.35% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Bercampur | Bercampur |
| Medical Devices (Global) | Bercampur | Bercampur | |
| Stok | Pheton Holdings Ltd | - | - |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | 0.0 |
| Purata | 0.17 |
|
Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 95.17% |
| % Dimiliki oleh Institusi | 0.27% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |